The growing interest of pharmaceutical and agri-business companies in genes from natural products is generating a complex set of conflicts with Third World nations, where most of the world's genetic diversity is to be found.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Rights and permissions
About this article
Cite this article
Macilwain, C. When rhetoric hits reality in debate on bioprospecting. Nature 392, 535–536 (1998). https://doi.org/10.1038/33237
Issue date:
DOI: https://doi.org/10.1038/33237
This article is cited by
-
Locating Responsible Research and Innovation Within Access and Benefit Sharing Spaces of the Convention on Biological Diversity: the Challenge of Emerging Technologies
NanoEthics (2016)
-
Exploitation of Microbial Diversity for Novel Products
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences (2012)
-
Harnessing biodiversity: the Malagasy Institute of Applied Research (IMRA)
BMC International Health and Human Rights (2010)
-
David Pearce and the economic valuation of biodiversity
Environmental and Resource Economics (2007)
-
Land-use system modeling and analysis of shaded cacao production in Belize
Agroforestry Systems (2005)
